Tiagabine Oral Tablet [Gabitril]
RxNorm 368199
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 368199 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tiagabine Oral Tablet [Gabitril].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Tiagabine Oral Tablet [Gabitril]
(Atom ID: 2052289)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
TiaGABine Oral Tablet [Gabitril]
(Atom ID: 3738297)
Patient Education
Tiagabine
Tiagabine is used in combination with other medications to treat partial seizures (a type of epilepsy). Tiagabine is in a class of medications called anticonvulsants. It is not known exactly how tiagabine works, but it increases the amount of natural chemicals in the brain that prevent seizure activity.
[Learn More]
* Please review the disclaimer below.